Go to the list of all blogs
Sergey Savastiouk's Avatar
published in Blogs
Sep 27, 2026
Exelon (EXC): Can the Stock Reclaim $50 for a Potential +24% Upside?

Exelon (EXC): Can the Stock Reclaim $50 for a Potential +24% Upside?

Key Takeaways

  • The selected price target is $50, a round-number psychological level and one of the most widely cited analyst price targets for Exelon, representing roughly 24% upside from recent trading near $40.
  • The strongest bullish factors include Exelon's regulated rate base growth, a multi-year capital investment plan, rising electricity demand from data centers and electrification, and a dividend yield above 4%.
  • The biggest risks are interest rate sensitivity, regulatory rate-case outcomes, and the execution risk tied to a large capital spending program.
  • Key levels to watch: the 52-week low near $39.73 serves as a support level, while the 52-week high of $50.65 set in March 2026 acts as the primary resistance level.
  • The key takeaway for investors: a return to $50 appears realistic over time but will likely depend more on interest rates and regulatory approvals than on earnings growth alone.

Why the $50 Level Stands Out

Exelon Corporation (EXC), one of the largest regulated electric and gas utilities in the United States, has drawn attention from investors considering whether the stock can return to the $50 mark. This level carries weight for a couple of reasons. It is a frequently referenced stock price target on Wall Street, with firms such as Morgan Stanley, Bank of America, and Wells Fargo having highlighted it. At the same time, $50 sits just below the stock's 52-week high of $50.65, creating a notable technical and psychological hurdle that would need to be cleared for any sustained recovery.

Company Background

Exelon operates as a pure-play transmission and distribution utility, serving about 10 million customers across six regulated subsidiaries, including ComEd in Illinois, PECO in Pennsylvania, and BGE in Maryland. After spinning off its power generation business, CEG (Constellation Energy), in 2022, the company shifted to a more stable, fee-based model focused on regulated rate base rather than fluctuating commodity prices. This setup is central to the discussion around $50, since Exelon's results are shaped primarily by regulators instead of power market dynamics.

Where the Stock Stands Today

Exelon has retreated from its March 2026 peak and has been trading near $40 in recent sessions, close to its 52-week low around $39.73. That pullback has lifted the dividend yield above 4%, a level that often draws income-focused investors. With a price-to-earnings ratio in the mid-teens and a beta near 0.39, the shares still offer defensive characteristics, though the recent softness mirrors broader pressure on utilities as markets weigh the effects of interest rates on capital-heavy, debt-funded operations.

Factors That Could Support a Move Higher

Several elements point to the potential for a rebound toward $50. Exelon has outlined a capital investment program exceeding $40 billion over the next several years, directed at grid modernization, reliability improvements, and renewable integration. This spending is intended to expand the rate base and support higher allowed earnings over time. In addition, growing electricity demand from data centers and broader electrification trends has strengthened the longer-term outlook for the sector. A meaningful drop in interest rates would reduce financing costs and enhance the appeal of the dividend relative to other income options, serving as one of the more direct catalysts for a higher valuation.

Obstacles That Could Limit Gains

Persistently high or rising interest rates represent the largest challenge. As a capital-intensive business, Exelon faces compressed returns and greater competition from fixed-income alternatives when borrowing costs increase. Regulatory outcomes across Illinois, Pennsylvania, and Maryland also matter, as they determine how much of the planned spending can be recovered through customer rates. Unfavorable rulings or delays could slow earnings growth. Execution risks on the large capital program, such as cost overruns or timeline slips, could also affect sentiment even if demand trends remain positive.

Analyst Views and Targets

The analyst community maintains a generally constructive but mixed stance. The consensus rating sits at "Hold," with an average price forecast near $48–$50 and a high target around $58. Several firms continue to reference $50 targets, while Evercore ISI has taken a more bullish stance with a target above $55 and an Outperform rating. Some targets have been adjusted downward recently, including Morgan Stanley's move to $50 from $53, reflecting the same interest-rate and regulatory considerations weighing on the shares. This range of views suggests $50 is within reach in many base cases, though it is not yet a uniform expectation.

Important Technical Levels

From a technical analysis standpoint, the picture centers on two main zones. Below the market, the 52-week low near $39.73 represents key support, and a sustained break under it could lead to additional weakness. Above, $50 serves as both a round-number milestone and the approximate location of the March 2026 high at $50.65, so clearing supply in that area would be needed to confirm a new uptrend. Reaching $50 from current levels would equate to roughly a 24% advance and would most likely require a shift in the broader macro environment rather than any single earnings report.

Monitoring Opportunities with AI Tools

I also checked this using Tickeron’s AI Screener to see how the stock compares to others in the industry. For those looking at a more systematic way to time entries and exits, Tickeron’s AI Daily Buy/Sell Signals can add another layer of data-driven perspective when tracking whether Exelon is building momentum toward $50.

Overall Outlook

In my view, Exelon reaching $50 is plausible but not immediate. The regulated rate base expansion, sizable capital plan, and structural demand from data centers and electrification form a solid long-term base. The clearest path to $50 hinges on a more supportive interest rate backdrop and favorable regulatory decisions. The main risks—higher financing costs, challenging rate-case results, and execution issues on the capital program—could keep the shares range-bound near current levels. Watching rate trends, quarterly regulatory updates, and the stock’s ability to hold the $39.73 support zone will be key to determining whether the next significant move heads toward $50 or stays further away.

Exploring Tickeron AI Tools

From what I see in my own research process, Tickeron’s AI Trading Bots have been useful for testing different scenarios on utility names like this one. The platform lets users set parameters and review historical performance across various market conditions, which can complement traditional analysis when evaluating longer-term targets such as $50. I find it helpful for spotting patterns that might not stand out from manual review alone.

Disclaimer

The information on this webpage is provided for general informational and educational purposes only and is not intended as investment advice, a recommendation to purchase or sell any security, or an offer or solicitation related to investments. It does not consider your personal financial situation, goals, or risk profile, and all investing carries inherent risks, including the possibility of losing your entire investment. For more details, please review our full disclaimer.

Disclaimers and Limitations

Related Ticker: EXC

Contributor

Sergey Savastiouk, Ph.D. has a degree in Applied Mathematics from Moscow University and has extensive experience as an entrepreneur, investor, manager, and mathematician. His professional expertise is in applied mathematics, mathematical modeling, system and pattern analysis, and software and hardware system integration. He has served as the CEO of several hi-tech start-up companies and nonprofit organizations, which has given him proven capabilities in business strategy for high-tech start-up companies, market assessment, company formation, team building, product development, marketing, and sales. He has published numerous articles in journals and magazines on related fields. As a retail investor, he spent 15 years developing his proprietary trading and quantitative algorithms (now Tickeron’s A.I.), which brought him significant returns in trading the stock market. His current work and goal in founding Tickeron is to bring professional, sophisticated stock market analysis capabilities to retail investors via an easy-to-use interface.


EXC in upward trend: price expected to rise as it breaks its lower Bollinger Band on September 23, 2026

EXC may jump back above the lower band and head toward the middle band. Traders may consider buying the stock or exploring call options. In 23 of 38 cases where EXC's price broke its lower Bollinger Band, its price rose further in the following month. The odds of a continued upward trend are 61%.

Price Prediction Chart

Technical Analysis (Indicators)

Bullish Trend Analysis

The RSI Indicator shows that the ticker has stayed in the oversold zone for 4 days. The price of this ticker is presumed to bounce back soon, since the longer the ticker stays in the oversold zone, the more promptly an Uptrend is expected.

The Stochastic Oscillator shows that the ticker has stayed in the oversold zone for 9 days. The price of this ticker is presumed to bounce back soon, since the longer the ticker stays in the oversold zone, the more promptly an upward trend is expected.

Following a +1.05% 3-day Advance, the price is estimated to grow further. Considering data from situations where EXC advanced for three days, in 179 of 337 cases, the price rose further within the following month. The odds of a continued upward trend are 53%.

Bearish Trend Analysis

The Momentum Indicator moved below the 0 level on September 09, 2026. You may want to consider selling the stock, shorting the stock, or exploring put options on EXC as a result. In 38 of 86 cases where the Momentum Indicator fell below 0, the stock fell further within the subsequent month. The odds of a continued downward trend are 44%.

The Moving Average Convergence Divergence Histogram (MACD) for EXC turned negative on September 14, 2026. This could be a sign that the stock is set to turn lower in the coming weeks. Traders may want to sell the stock or buy put options. Tickeron's A.I.dvisor looked at 44 similar instances when the indicator turned negative. In 21 of the 44 cases the stock turned lower in the days that followed. This puts the odds of success at 48%.

The 50-day moving average for EXC moved below the 200-day moving average on September 14, 2026. This could be a long-term bearish signal for the stock as the stock shifts to an downward trend.

Following a 3-day decline, the stock is projected to fall further. Considering past instances where EXC declined for three days, the price rose further in 50 of 62 cases within the following month. The odds of a continued downward trend are 48%.

The Aroon Indicator for EXC entered a downward trend on September 25, 2026. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options.

Fundamental Analysis (Ratings)

The Tickeron Valuation Rating of 15 (best 1 - 100 worst) indicates that the company is slightly undervalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (1.399) is normal, around the industry mean (1.685). P/E Ratio (14.831) is within average values for comparable stocks, (16.793). Projected Growth (PEG Ratio) (2.168) is also within normal values, averaging (1.932). Dividend Yield (0.041) settles around the average of (0.036) among similar stocks. P/S Ratio (1.709) is also within normal values, averaging (85.686).

The Tickeron Profit vs. Risk Rating rating for this company is 51 (best 1 - 100 worst), indicating well-balanced risk and returns. The average Profit vs. Risk Rating rating for the industry is 58, placing this stock slightly better than average.

The Tickeron PE Growth Rating for this company is 54 (best 1 - 100 worst), pointing to consistent earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.

The Tickeron Price Growth Rating for this company is 62 (best 1 - 100 worst), indicating fairly steady price growth. EXC’s price grows at a lower rate over the last 12 months as compared to S&P 500 index constituents.

The Tickeron SMR rating for this company is 72 (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.

Notable companies

The most notable companies in this group are Nextera Energy Inc (NYSE:NEE), Southern Company (The) (NYSE:SO), Dominion Energy (NYSE:D), PG&E Corp (NYSE:PCG).

Industry description

Electric utilities companies generate, transmit and distribute electricity to businesses/offices and residences. Companies may be owned by the government or investors or public shareholders, or a combination thereof. The industry also includes firms that buy and sell electricity. Companies in this industry typically require significant investments in infrastructure. Many firms in this industry pay substantial and regular dividends to shareholders. However, changes in interest rates (and their impact on debt burdens), natural disasters and changing commodity prices could be factors affecting energy utilities’ profit margins. NextEra Energy, Inc., Duke Energy Corporation, Dominion Energy Inc. and Southern Company are among U.S. electric utilities companies with the largest market capitalizations.

Market Cap

The average market capitalization across the Electric Utilities Industry is 28.25B. The market cap for tickers in the group ranges from 300 to 158.7B. NEE holds the highest valuation in this group at 158.7B. The lowest valued company is SLTZ at 300.

High and low price notable news

The average weekly price growth across all stocks in the Electric Utilities Industry was -3%. For the same Industry, the average monthly price growth was -8%, and the average quarterly price growth was -10%. IMSR experienced the highest price growth at 3%, while NKLR experienced the biggest fall at -11%.

Volume

The average weekly volume growth across all stocks in the Electric Utilities Industry was -38%. For the same stocks of the Industry, the average monthly volume growth was 53% and the average quarterly volume growth was 16%

Fundamental Analysis Ratings

The average fundamental analysis ratings, where 1 is best and 100 is worst, are as follows

Valuation Rating: 37
P/E Growth Rating: 55
Price Growth Rating: 61
SMR Rating: 69
Profit Risk Rating: 58
Seasonality Score: -51 (-100 ... +100)
View a ticker or compare two or three
EXC
Daily Signal:
Gain/Loss:
Interact to see
Advertisement
A.I.Advisor
published price charts
A.I. Advisor
published General Information

General Information

a company which purchases, transmits and distributes electricity

Industry ElectricUtilities

Industry
Electric Utilities
Address
10 South Dearborn Street
Phone
+1 800 483-3220
Employees
41182
Web
https://www.exeloncorp.com
Interact to see
Advertisement
NTGR shares surged approximately 11% in premarket trading on March 24, 2026, building on a roughly 20% overnight jump in the prior session. The primary catalyst is a landmark Federal Communications Commission (FCC) ruling that prohibits all imports of consumer routers manufactured overseas, citing national security concerns.
ANNA is surging approximately +20.00% in Tuesday's premarket session, rebounding sharply from Monday's -22.84% decline. The primary catalyst remains the ongoing U.S.-Iran military conflict, which disrupted Qatari LNG exports and drove European benchmark natural gas prices to multi-year highs.
Concentrix Corporation (CNXC) shares are falling approximately 11% in Tuesday's premarket session after the company released its fiscal Q1 2026 earnings report before market open. Adjusted diluted EPS came in at $2.61, missing the Wall Street consensus estimate of approximately $2.64.
Shares of Karyopharm Therapeutics (KPTI) are trading approximately 12% lower in Tuesday's premarket session, with the previous close at $7.63. The primary catalyst is the March 24 release of topline Phase 3 SENTRY trial data, in which the company met only one of two co-primary endpoints.
IBRX shares are down approximately 23% in Tuesday's session, trading near $7.24 after closing at $9.40 on Monday, March 23. The sharp decline follows an 11%+ surge in the prior session, with profit-taking and valuation pressure cited as primary triggers.
Shares of Circle Internet Group (CRCL) are down approximately 9% in Tuesday morning trading, extending a pullback from recent multi-month highs above $126. The primary catalyst appears to be a broad crypto-sector risk-off wave, with Bitcoin sliding below $69,000 and the Fear & Greed Index dropping to extreme fear territory.
ALM shares are indicated down about 11% in early Tuesday trading after closing the prior session at $16.93. The move comes after a powerful multi‑month rally that took the stock from below $3 to an intraday high of $22.55 earlier in March, leaving it vulnerable to profit-taking and volatility.​
LUNR shares are indicated down about 7% in Tuesday premarket trading after closing the last regular session at $20.31. The pullback follows a powerful rally driven by strong 2026 revenue guidance of $900 million–$1 billion and upbeat analyst commentary, including price target hikes and buy ratings.
MAZE shares are trading approximately 27% lower in premarket on March 25, 2026, after the company reported its highly anticipated Phase 2 HORIZON trial topline data for lead drug candidate MZE829. The catalyst is a dual announcement: Phase 2 clinical data for MZE829 in APOL1-mediated kidney disease (AMKD) alongside Q4 and full-year 2025 financial results.
ARM shares surged approximately +10% in premarket trading on March 25, 2026, hitting $148.6 from a prior close of approximately $135. The primary catalyst is Arm's historic strategic pivot: the company announced it will begin selling its own self-developed AGI CPU chips, breaking its decades-long "IP licensing only" business model.
Shares of Enliven Therapeutics (ELVN) are surging approximately +15% in premarket trading on March 25, 2026, driven by renewed investor enthusiasm around the company's advancing clinical program for ELVN-001 in chronic myeloid leukemia (CML). The stock's prior closing price on March 24, 2026 was $31.15, placing the premarket indicated price near $35.82.
AVXL shares are down approximately 29% in premarket trading on Wednesday, March 25, 2026, falling to roughly $2.97 from the prior close of $4.19. The primary catalyst is Anavex's formal withdrawal of its marketing authorization application (MAA) for blarcamesine from the European Union, announced in the early hours of March 25, 2026.
Shares of GSAT are surging approximately +15% intraday on March 25, 2026, following a prior session close of $61.09. The primary catalyst is a fresh analyst note from Scotiabank highlighting Globalstar's direct-to-device satellite connectivity bypassing cellular towers — most notably in Mexico — reinforcing the company's next-generation infrastructure thesis.
Shares of ADMA are declining approximately 12% in Wednesday's session, extending a steep two-day selloff. The primary catalyst is a short-seller research report published by Culper Research on March 24, 2026, alleging that ADMA engaged in channel stuffing to artificially inflate revenue growth.
Honeywell International (HON) and TransDigm Group (TDG) are prominent players in the aerospace and industrials sector, benefiting from rising air travel demand, defense spending, and aftermarket services. This stock comparison evaluates their business models, recent performance, and market positioning to help traders and investors assess relative strengths in the current environment. With global aviation recovery and geopolitical tensions supporting sector tailwinds, professionals seeking exposure to aerospace growth versus diversified industrials stability will find these insights relevant for portfolio decisions and relative performance analysis.
PL shares are surging approximately +15% in Wednesday's session, trading near $35.89, pushing back toward the stock's 52-week high of $36.28 set on March 20, 2026. Primary catalyst: Continued momentum from a blockbuster Q4 fiscal 2026 earnings report delivered March 19, which sent revenue 41% higher year-over-year to $86.8 million, well above the $78 million Wall Street consensus.
ASTS shares surged approximately +11.00% in active intraday trading on March 25, 2026, moving from a prior close of $86.98 to approximately $96.55. The primary driver is a broad space sector rally fueled by renewed SpaceX IPO speculation, lifting satellite and space-related equities across the board.
FUBO shares are set to open about 12% lower in Wednesday’s premarket session after closing the prior day at roughly $12.02. The decline follows a strong multi-week rally powered by balance-sheet news, including the repurchase of $140.2 million of 2026 convertible notes and improving profitability trends.
One & One Green Technologies Inc. (YDDL) shares are indicated down about 13% in Wednesday’s premarket session after closing the prior regular session at $12.00. The stock had just surged 15.6% in the latest completed session, jumping from a prior close of $10.38 to $12.00, leaving it vulnerable to swift profit‑taking and volatility.
AVXL shares are indicated down about 33% in Wednesday’s premarket session, after closing the prior regular session at $4.19. The slide follows a recent drop triggered by a wider‑than‑expected fourth‑quarter loss and ongoing questions about the company’s late‑stage neurology pipeline.
Exelon (EXC): Can the Stock Reclaim $50 for a Potential +24% Upside?